Vita 34 AG
XETRA:V3V
Vita 34 AG
Accounts Payable
Vita 34 AG
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Accounts Payable
€9.9m
|
CAGR 3-Years
96%
|
CAGR 5-Years
55%
|
CAGR 10-Years
24%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Accounts Payable
€725.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Accounts Payable
€1.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
4%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Accounts Payable
HK$22.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Accounts Payable
€289.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Accounts Payable?
Accounts Payable
9.9m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Accounts Payable amounts to 9.9m EUR.
What is Vita 34 AG's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
24%
Over the last year, the Accounts Payable growth was 23%. The average annual Accounts Payable growth rates for Vita 34 AG have been 96% over the past three years , 55% over the past five years , and 24% over the past ten years .